She specializes in sustainable weight management, including nutrition support for patients using GLP-1 therapies
Several possible reasons for the lack of efficacy of antioxidants in clinical trials include (i) insufficient antioxidant levels in the target organ, especially in the nervous system, because an integrated bloodbrain barrier (BBB) is a major obstacle to delivering desired substances, including antioxidants, into the CNS
June 2026 update: FDA issues 25 more warning letters to telehealth companies During the week of June 15, 2026 - days before this article was published - the FDA issued 25 additional warning letters to telehealth companies over false or misleading promotional claims about compounded GLP-1 products
How do I know if I qualify for treatment
Zhang L, Ludden CM, Cullen AJ, Tew KD, Branco de Barros AL, Townsend DM
How does PlexusDx help patients stay consistent with semaglutide timing